4-anilino quinazoline derivatives as antiproliferative agents

Details for Australian Patent Application No. 2003214443 (hide)

Owner AstraZeneca AB

Inventors Hennequin, Laurent Francois Andre; Bradbiru, Robert Hugh; Kettle, Jason Grant

Agent Davies Collison Cave

Pub. Number AU-B-2003214443

PCT Number PCT/GB03/01306

PCT Pub. Number WO2003/082831

Priority 0230086.1 24.12.02 GB; 0207323.7 28.03.02 GB; 0301916.3 28.01.03 GB

Filing date 26 March 2003

Wipo publication date 13 October 2003

Acceptance publication date 16 July 2009

International Classifications

C07D 403/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

A61K 31/517 (2006.01) - ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine

A61K 31/5377 (2006.01)

A61P 9/10 (2006.01) Drugs for disorders of the cardiovascular system

A61P 13/08 (2006.01) Drugs for disorders of the urinary system

A61P 17/06 (2006.01) Drugs for dermatological disorders

A61P 35/00 (2006.01) Antineoplastic agents

A61P 35/02 (2006.01) Antineoplastic agents

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

C07D 239/94 (2006.01) Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

C07D 401/12 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 401/14 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 403/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 491/04 (2006.01) Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or

C07D 491/056 (2006.01) Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or

Event Publications

31 July 2003 Complete Application Filed

  Priority application(s): 0230086.1 24.12.02 GB; 0207323.7 28.03.02 GB; 0301916.3 28.01.03 GB

20 November 2003 Application Open to Public Inspection

  Published as AU-B-2003214443

16 July 2009 Application Accepted

  Published as AU-B-2003214443

20 August 2009 Corrigenda

  Applications Accepted - Name Index Under the name AstraZeneca AB, Application No. 2003214443, under INID (72) correct the co-inventor to Bradbury, Robert Hugh

26 November 2009 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003214444-Improvements in or relating to tiltable mountings for payloads

2003214442-Heteroaromatic urea derivatives as VR1 receptor modulators for treating pain